[ad_1]
DUBLIN July 18, 2018 / PRNewswire / – United Neuroscience, Ltd., (UNS), a clinical stage biotechnology company specializing in the treatment of Alzheimer's disease, announced today As the company will be present at the next International Conference of the Alzheimer's Association (AAIC) to be held on 22-26 July 2018 Chicago . AAIC is the first annual conference for the presentation and discussion of the latest research on Alzheimer's and dementia.
"At United Neuroscience, we envision a world where vaccines are used to treat and eventually prevent Alzheimer's disease," Ajay Verma MD, Ph.D., CMO of United Neuroscience. "We have built a robust translational platform to quickly design and develop targeted immunotherapies based on state-of-the-art inactivation vaccine technology. Our presence at AAIC this year demonstrates our commitment to transforming the lives of all patients." and families affected by Alzheimer's disease.
Poster Details of the presentation:
Title: Basic Characteristics for Patients with mild Alzheimer's Disease enrolled in Phase IIa Active Immunotherapeutic Vaccine Trial UB-311
Date: 2018
Time: 9:30 – 4:15 pm CDT
Location: Hall – F1, McCormick Place, Chicago
Abstract Number: P1-037
About AAIC
The International Conference of the Alzheimer's Association® (AAIC®) is the International Meeting the most important and influential one devoted to advancing the science of dementia. The conference brings together leading researchers, clinicians and the global healthcare research community to communicate discoveries that will lead to methods of prevention and treatment of Alzheimer's disease. For more information on AAIC, please visit www.alz.org/aaic.
About United Neuroscience
United Neuroscience (UNS) is a clinical-stage biotechnology company focused on the development of first-rate immunotherapies for the brain. A global company headquartered in Dublin, Ireland with operations in Taiwan and in the United States UNS was founded to address the social and economic burden of disease. Alzheimer's and other neurodegenerative diseases. Advance candidates in and through clinical trials to provide revolutionary treatments to patients. For more information, visit www.unitedneuroscience.com. Follow UNS on Twitter at https://twitter.com/UNSTechBio and on LinkedIn at https://www.linkedin.com/company/unitedneuroscience.
Media Contacts [19659002] David Schull or Brittanie Dougherty
Russo Partners, LLC
(212) 845-4271
(646) 942-5634
david.schull@russopartnersllc. com
[email protected]
See the original article: http: //www.prnewswire.com/news-releases/united -neuroscience-announces-presentation-at-the-2018-alzheimers-international-conference-association-aaic-300682981.html
SOURCE United Neuroscience, Ltd.
[ad_2]
Source link
